Ethyl 2-(7-bromoimidazo[1,2-a]pyridin-3-yl)acetate

Catalog No. :
ACSLXY491
CAS No. :
1363383-34-9
Molecular Formula :
C11H11BrN2O2
Molecular Weight :
283.13

IUPAC Name:ethyl 2-(7-bromoimidazo[1,2-a]pyridin-3-yl)acetate

Ethyl 2-(7-bromoimidazo[1,2-a]pyridin-3-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$51.00Login to see priceIn stockIn stock
250mg95%$104.00Login to see priceIn stockIn stock
1g95%$280.00Login to see priceIn stockIn stock
5g95%$1051.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-(7-bromoimidazo[1,2-a]pyridin-3-yl)acetate
IUPAC Nameethyl 2-(7-bromoimidazo[1,2-a]pyridin-3-yl)acetate
MDL No.MFCD21642015
Molecular FormulaC11H11BrN2O2
Molecular Weight283.13
SMILESO=C(OCC)CC1=CN=C2C=C(Br)C=CN21
InChI KeyAWWKGXJTUNFUSL-UHFFFAOYSA-N
SynonymIMidazo[1,2-a]pyridine-3-acetic acid, 7-broMo-, ethyl ester;ETHYL 2-(7-BROMOIMIDAZO[1,2-A]PYRIDIN-3-YL)ACETATE;Ethyl 6-bromoimidazo[1,2-a]pyridine-3-acetate
CAS No.1363383-34-9
PubChem CID71819683

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACSLXY491 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSLXY491 route product structure diagram
    ACSLXY4911363383-34-9 In Stock
Inquiry

2. ACSLXY491 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSLXY491 route product structure diagram
    ACSLXY4911363383-34-9 In Stock
Inquiry

Comments (0)